Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2016 2
2018 4
2019 2
2020 4
2021 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
Heugenhauser J, Galijasevic M, Mangesius S, Goebel G, Buchroithner J, Erhart F, Pichler J, Widhalm G, Stockhammer G, Iglseder S, Freyschlag CF, Oberndorfer S, Bordihn K, von Campe G, Czech T, Surböck B, Urbanic Purkart T, Marosi C, Felzmann T, Nowosielski M. Heugenhauser J, et al. Among authors: erhart f. Cancers (Basel). 2022 Mar 20;14(6):1579. doi: 10.3390/cancers14061579. Cancers (Basel). 2022. PMID: 35326730 Free PMC article.
IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.
Dillinger B, Ahmadi-Erber S, Lau M, Hoelzl MA, Erhart F, Juergens B, Fuchs D, Heitger A, Ladisch S, Dohnal AM. Dillinger B, et al. Among authors: erhart f. Cell Immunol. 2018 Mar;325:33-40. doi: 10.1016/j.cellimm.2018.01.014. Epub 2018 Feb 2. Cell Immunol. 2018. PMID: 29402391 Free PMC article.
Fibroblast growth factor receptor 4 promotes glioblastoma progression: a central role of integrin-mediated cell invasiveness.
Gabler L, Jaunecker CN, Katz S, van Schoonhoven S, Englinger B, Pirker C, Mohr T, Vician P, Stojanovic M, Woitzuck V, Laemmerer A, Kirchhofer D, Mayr L, LaFranca M, Erhart F, Grissenberger S, Wenninger-Weinzierl A, Sturtzel C, Kiesel B, Lang A, Marian B, Grasl-Kraupp B, Distel M, Schüler J, Gojo J, Grusch M, Spiegl-Kreinecker S, Donoghue DJ, Lötsch D, Berger W. Gabler L, et al. Among authors: erhart f. Acta Neuropathol Commun. 2022 Apr 28;10(1):65. doi: 10.1186/s40478-022-01363-2. Acta Neuropathol Commun. 2022. PMID: 35484633 Free PMC article.
The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers.
Mischkulnig M, Kiesel B, Rötzer-Pejrimovsky T, Borkovec M, Lang A, Millesi M, Wadiura LI, Hervey-Jumper S, Penninger JM, Berger MS, Widhalm G, Erhart F. Mischkulnig M, et al. Among authors: erhart f. Front Mol Neurosci. 2022 Sep 14;15:928355. doi: 10.3389/fnmol.2022.928355. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187350 Free PMC article.
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
Lang A, Jeron RL, Lontzek B, Kiesel B, Mischkulnig M, Berghoff AS, Ricken G, Wöhrer A, Rössler K, Lötsch-Gojo D, Roetzer-Pejrimovsky T, Berger W, Hainfellner JA, Höftberger R, Widhalm G, Erhart F. Lang A, et al. Among authors: erhart f. J Neurooncol. 2023 Aug;164(1):211-220. doi: 10.1007/s11060-023-04406-3. Epub 2023 Aug 6. J Neurooncol. 2023. PMID: 37543970 Free PMC article.
Analysis of corticosteroid and antiepileptic drug treatment effects on heme biosynthesis mRNA expression in lower-grade gliomas: Potential implications for 5-ALA metabolization.
Mischkulnig M, Sperl V, Erhart F, Kiesel B, Lang A, Hosmann A, Roetzer T, Makolli J, Traxler D, Borkovec M, Rössler K, Widhalm G, Wadiura LI. Mischkulnig M, et al. Among authors: erhart f. Photodiagnosis Photodyn Ther. 2022 Jun;38:102755. doi: 10.1016/j.pdpdt.2022.102755. Epub 2022 Feb 9. Photodiagnosis Photodyn Ther. 2022. PMID: 35149260
Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.
Erhart F, Hackl M, Hahne H, Buchroithner J, Meng C, Klingenbrunner S, Reitermaier R, Fischhuber K, Skalicky S, Berger W, Spiegl-Kreinecker S, Lötsch D, Ricken G, Kuster B, Wöhrer A, Widhalm G, Hainfellner J, Felzmann T, Dohnal AM, Marosi C, Visus C. Erhart F, et al. NPJ Vaccines. 2020 Jan 16;5(1):5. doi: 10.1038/s41541-019-0149-x. eCollection 2020. NPJ Vaccines. 2020. PMID: 31969991 Free PMC article.
21 results